Califf allies have argued that he conducted himself with integrity while working with drug companies and that his expertise on scientific data and clinical trials would prove valuable to the FDA. Shortly before the Senate vote, Sen. Patty Murray (D-Wash.), the chair of the Health, Education, Labor and Pensions Committee, and Burr, the ranking Republican, urged their colleagues to confirm Califf.
Source Article from https://www.washingtonpost.com/health/2022/02/15/califf-fda-commissioner/
Comments